Quarterly-estimates

Best Buy tops quarterly estimates, raises outlook as computing shows strength

Best Buy raised its full fiscal-year outlook on Thursday after reporting a stronger-than-expected first-half performance.

Nvidia forecasts quarterly revenue above estimates, shares rise

Nvidia's quarterly revenue more than doubled and the chipmaker forecast third-quarter revenue above Wall Street estimates on Wednesday, signaling persistent de…

CleanSpark misses Wall Street revenue estimates as shares sink

CleanSpark's shares fell 5.5% on Thursday after the Bitcoin miner reported $138 million in quarterly revenue, narrowly missing Wall Street's consensus estimate.

Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge

Eli Lilly now expects 2026 revenue to come in between $85 billion and $87 billion, up from a previous guidance of $82 billion and $85 billion.

Humana tops quarterly estimates, maintains profit outlook as medical costs stay in line

Humana maintained its 2026 adjusted profit outlook of at least $9 per share, which some analysts called a "disappointment" amid high expectations for insurers.

Procter & Gamble revenue misses estimates as volume stays unchanged

Procter & Gamble reported quarterly earnings per share that topped Wall Street's estimates, but its revenue fell short of expectations.

Domino's misses quarterly sales, profit estimates on weak demand, competition

Domino's quarterly sales have slid as fears of higher living costs and a sluggish U.S. job market discourage consumers from splurging on dining out.

J&J quarterly earnings beat Wall Street estimates on strength of medicines unit

Johnson & ⁠Johnson also increased its full-year sales and ⁠profit ‌forecast.

Expedia beats quarterly estimates, flags hit from Middle East war

AON (NYSE:AON) Posts Earnings Results, Beats Estimates By $0.11 EPS

AON (NYSE:AON - Get Free Report) posted its quarterly earnings data on Friday. The financial services provider reported $6.48 earnings per share for the quarte…

Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket

Lilly hiked its full-year sales outlook by $2 billion, and also raised its adjusted profit guidance.

Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook

Merck narrowed its 2026 sales guidance and hiked its adjusted profit outlook.

Southwest Airlines forecasts quarterly earnings below estimates on higher fuel

The airline reported that revenue in its first-quarter period rose nearly 13% to $7.25 billion.

UnitedHealth tops quarterly estimates, hikes profit outlook as insurer manages high medical costs

The nation's largest private insurer expects 2026 adjusted earnings of more than $18.25 per share, up from a previous outlook of greater than $17.75 per share.

PepsiCo earnings beat estimates as Doritos, Lay's price cuts win back shoppers

PepsiCo's quarterly earnings and revenue topped Wall Street's expectations.

Citigroup beats estimates, boosted by gains in fixed income

Citigroup reported its best quarterly revenue in a decade and a 56% year-over-year jump in earnings per share.

Targa Resources (NYSE:TRGP) Issues Quarterly Earnings Results, Beats Estimates By $0.16 EPS

Targa Resources (NYSE:TRGP - Get Free Report) issued its quarterly earnings results on Thursday. The pipeline company reported $2.51 EPS for the quarter, beati…

CVS tops quarterly estimates, reaffirms profit outlook as turnaround plan takes effect

The results signal steady progress in the health-care giant's aggressive turnaround plan under CEO David Joyner, who stepped into the role in late 2024.

Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar

Eli Lilly's full-year guidance comes in stark contrast to the outlook of Novo Nordisk, which warned it sees sales and profit declining as much as 13% this year.

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

The pharmaceutical giant reaffirmed the modest 2026 outlook that rattled investors in December.